Inotiv shares early Q4 & FY 2025 figures and conference webcast plan

Rhea-AI Filing Summary

Inotiv, Inc. (NOTV) announced that it has issued a press release with select preliminary unaudited financial results for its fourth quarter and fiscal year ended September 30, 2025. These early figures are being shared ahead of final audited results to give the market an initial view of the company’s recent performance.

The company also disclosed that President and CEO Robert Leasure, Jr. will present at the Jefferies Global Healthcare Conference on November 18, 2025 at 6:00 a.m. Eastern time. A live webcast and replay of this presentation will be available through the Investors section of Inotiv’s website. The press release containing the preliminary results is furnished as Exhibit 99.1.

0000720154FALSE00007201542025-11-172025-11-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): (November 17, 2025)

INOTIV, INC.

(Exact name of registrant as specified in its charter)

Indiana

0-23357

35-1345024

(State or other jurisdiction of  incorporation)

(Commission File Number)

(IRS Employer Identification No.)

2701 KENT AVENUE WEST LAFAYETTE,INDIANA						47906-1382
(Address of principal executive offices)						(Zip Code)

Registrant's telephone number, including area code: (765) 463-4527

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange  on which registered

Common Shares

NOTV

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 2.02.    Results of Operations and Financial Condition.

On November 17, 2025, Inotiv, Inc. (the “Company”) issued a press release providing select preliminary unaudited financial results for the fourth quarter and fiscal year ended September 30, 2025 and disclosing that the presentation by Robert Leasure, Jr., the Company President and Chief Executive Officer, at the Jefferies Global Healthcare Conference is now scheduled for November 18, 2025 at 6:00 a.m. Eastern time. The live webcast and an online replay of Mr. Leasure’s presentation will be accessible in the Investors section of the Company’s web site. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

The information provided in Item 2.02 and Item 9.01, including Exhibit 99.1, of this Form 8-K is being furnished and shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01.    Financial Statements and Exhibits.

(d)Exhibits

Exhibit No.						Description
99.1						Inotiv, Inc. press release, issued November 17, 2025.
104						Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

						INOTIV, INC.
Date:			November 17, 2025			By:			/s/ Beth A. Taylor
									Chief Financial Officer,
									Executive Vice President

FAQ

What did Inotiv, Inc. (NOTV) announce in this 8-K filing?

Inotiv, Inc. reported that it issued a press release with select preliminary unaudited financial results for its fourth quarter and fiscal year ended September 30, 2025, and provided details about an upcoming investor conference presentation.

Which periods do Inotiv's preliminary results in the press release cover?

The preliminary unaudited financial results disclosed in the press release cover Inotiv’s fourth quarter and fiscal year ended September 30, 2025.

When and where will Inotiv’s CEO present at the Jefferies Global Healthcare Conference?

President and CEO Robert Leasure, Jr. is scheduled to present at the Jefferies Global Healthcare Conference on November 18, 2025 at 6:00 a.m. Eastern time.

How can investors access the webcast of Inotiv’s Jefferies conference presentation?

The live webcast and an online replay of Robert Leasure, Jr.’s presentation will be accessible in the Investors section of Inotiv’s website.

What exhibit contains Inotiv’s preliminary financial results press release?

The press release with Inotiv’s select preliminary unaudited financial results, issued on November 17, 2025, is furnished as Exhibit 99.1.

Is the information in this Inotiv 8-K considered filed or furnished?

The information provided under Item 2.02 and Item 9.01, including Exhibit 99.1, is being furnished and is not deemed “filed” for purposes of Section 18 of the Exchange Act.